Stock SLRN ACELYRIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Acelyrin, Inc.

Equities

SLRN

US00445A1007

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
4.12 USD +1.73% Intraday chart for Acelyrin, Inc. -0.24% -44.77%
22/05 HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating MT
14/05 Acelyrin, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart calendar Acelyrin, Inc.

882cc5600.yHVB31duv3NHpj6bglL6i48Z5VzOTHT3TKnma_Wjuvk.vh5xtzEq0CMl327v8Rqz0tx_sCaUeB6BHebUPaLB7KC7AyqbCC_rLBDqTQ~149ebad189e575212898507877414b65

Upcoming events on Acelyrin, Inc.

05/06/2024 10:55 pm Jefferies Global Healthcare Conference - Fireside Chat
07/06/2024 09:30 pm Annual General Meeting
12/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
27/03/2025 Q4 2024 Earnings Release (Projected)
12/06/2025 Q1 2025 Earnings Release (Projected)

Past events on Acelyrin, Inc.

14/05/2024 02:00 am Q1 2024 Earnings Call
13/05/2024 Q1 2024 Earnings Release
29/03/2024 01:35 am Q4 2023 Earnings Release
20/03/2024 06:00 pm Lonigutamab Phase 1/2 Proof of concept Data in Thyroid Eye Disease Call
11/03/2024 Investor Meeting
15/02/2024 Investor Meeting
16/11/2023 02:30 pm Jefferies London Healthcare Conference
08/11/2023 03:00 am Q3 2023 Earnings Call
08/11/2023 02:35 am Q3 2023 Earnings Release
13/09/2023 09:00 pm Morgan Stanley Global Healthcare Conference
12/09/2023 03:00 am Izokibep Phase 2b/3 Trial Results Call
15/08/2023 02:00 am Q2 2023 Earnings Call
15/08/2023 01:35 am Q2 2023 Earnings Release
16/06/2023 01:35 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00


0,00
-416
-
-416

EBIT
Million USD		Released
Forecast
Spread 		0,00


-422
-418
-0.93%
-368

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-382
-386
1.23%
-310

Net income
Million USD		Released
Forecast
Spread 		-64,8


-382
-386
1.23%
-310

EPS
USD		Released
Forecast
Spread 		-21,1


-5,43
-7,14
23.92%
-3,05

Announcement Date13/04/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread









-99,1

-82,7
-101
18.02%
-103


-105










EBIT
Million USD		Released
Forecast
Spread


-42,7
-59,8
28.64%		-94,4
-46,1
-104.82%		-105
-99,3
-5.9%		-82,8
-99,8
17.02%
-84,6


-91,9


-101


-116


-118

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-26,0
-60,7
57.13%		-83,9
-41,7
-101.42%		-95,2
-95,0
-0.2%		-35,0
-95,0
63.17%
-68,1


-79,2


-96,1


-116


-118

Net income
Million USD		Released
Forecast
Spread 		-176


-26,0
-60,7
57.13%		-83,9
-41,7
-101.42%		-95,2
-95,0
-0.2%		-35,0
-95,0
63.17%
-68,1


-79,2


-96,1


-116


-118

EPS
USD		Released
Forecast
Spread 		-8,61


-0,40
-0,85
52.66%		-0,87
-0,47
-86.7%		-0,75
-0,99
23.93%		-0,36
-0,98
63.23%
-0,69


-0,80


-0,93


-1,16


-1,17

Announcement Date15/06/2314/08/2307/11/2328/03/2414/05/24-----

Upcoming sector events for Acelyrin, Inc.

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Acelyrin, Inc.

17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 05:30 pm IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SLRN Stock
  4. Calendar Acelyrin, Inc.